Pulse Biosciences, Inc

PLSE Healthcare Medical Instruments & Supplies

Pulse Biosciences, Inc’s revenue for fiscal 2025 (year ended December 2025) was $350,000.00, down 50.0% from fiscal 2022.

Revenue
+359.3%
EPS
−10.3%
Free cash flow
−1,180.5%

Quarter to September 2026, against a year earlier

53.15 3.91 −6.85%
Market cap
$3.9B
P/E
0.0×
Fwd P/E
−38.1×
Dividend yield
—
F-score
n/a
Altman Z
31.41
Beneish M
n/a
Dividend safety
n/a

Pulse Biosciences, Inc (PLSE) Book value per share

Alert me on Book value per share

Pulse Biosciences, Inc's book value per share at the end of fiscal 2025 was 1.2×, down 39.2% from 2.0× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 2.6×. Over the past ten years it has ranged from −0.1× (fiscal 2022) to 3.9× (fiscal 2018); the current reading is higher than 36% of that period. Pulse Biosciences, Inc ranks 35th of 52 Medical Instruments & Supplies companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 1.2× (39.15%)
FY2024 2.0× 120.53%
FY2023 0.9× —
FY2022 −0.1× —
FY2021 1.3× 29.60%
FY2020 1.0× (33.53%)
FY2019 1.5× (61.86%)
FY2018 3.9× 24.59%
FY2017 3.1× 35.67%
FY2016 2.3× 27.22%

Quarterly newest first

Period Book value per share Change
Sep 2026 2.6× 77.49%
Jun 2026 1.4× 47.48%
Mar 2026 1.0× (18.53%)
Dec 2025 1.2× (13.00%)
43 more quarters

Against its own ten years

Low −0.1× High 3.9×
Ten-year median 1.5×
Current reading's percentile 36

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on PLSE